PoliticalRepoPoliticalRepo

United States · Law · HR

H.R. 3216 (103rd)

Domestic Chemical Diversion Control Act of 1993

enactedUnited States· United States Congress· EN

Introduced

5 October 1993

Last action

17 December 1993 · President

Status

Became Public Law No: 103-200.

Sponsors

Rep. Stupak, Bart [D-MI-1], Rep. Holden, Tim [D-PA-17], Rep. Oberstar, James L. [D-MN-8], Rep. Roth, Toby [R-WI-8], Rep. Saxton, Jim [R-NJ-13], Rep. Carr, Bob [D-MI-6], Rep. Foglietta, Thomas M. [D-PA-1], Rep. Coppersmith, Sam [D-AZ-1], Rep. Blackwell, Lucien E. [D-PA-2], FRED UPTON, Rep. Barrett, Thomas M. [D-WI-5]

Subjects

Healthcare

Source updated

3 June 2026

Healthcare

Summary

Domestic Chemical Diversion Control Act of 1993 - Amends the Controlled Substances Act to remove ephedrine products from the legal drug exemption of the Chemical Diversion and Trafficking Act (which currently precludes the application of any of the regulatory control measures of such Act to a listed chemical which is contained in a drug product approved under the Federal Food, Drug, and Cosmetic Act). Directs the Attorney General to remove from exemption any other drug products which are being diverted to use in the illicit production of controlled substances. Establishes a registration system for distributors, importers, and exporters of listed chemicals which are diverted within the United States. Directs the Attorney General to register an applicant to distribute, and to import or export, a list I (currently, listed precursor) chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest, based on specified criteria. Amends the Controlled Substances Import and Export Act to set penalties for knowingly or intentionally importing or exporting a listed chemical in violation of such registration requirements. Makes provisions of the Controlled Substances Act regarding administrative inspections and authority, forfeiture, and threshold amounts of substances applicable to listed chemicals, as well as to controlled substances. (Currently only the latter are covered by such provisions.)

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 5 October 1993

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 5 October 1993

    Introduced

    Sponsor introductory remarks on measure. (CR E2341)

    Source: IntroReferral

  3. 5 October 1993

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 5 October 1993

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 8 October 1993

    Referred

    Referred to the Subcommittee on Crime and Criminal Justice.

    Source: Committee

  6. 13 October 1993

    Introduced

    Sponsor introductory remarks on measure. (CR H7713)

    Source: IntroReferral

  7. 26 October 1993

    Referred

    Referred to the Subcommittee on Health and the Environment.

    Source: Committee

  8. 3 November 1993

    Introduced

    Sponsor introductory remarks on measure. (CR H8791-8793)

    Source: IntroReferral

  9. 10 November 1993

    Committee

    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote.

    Source: Committee

  10. 10 November 1993

    Committee

    Subcommittee Consideration and Mark-up Session Held.

    Source: Committee

  11. 16 November 1993

    Reported

    Ordered to be Reported (Amended) by Voice Vote.

    Source: Committee

  12. 16 November 1993

    Committee

    Committee Consideration and Mark-up Session Held.

    Source: Committee

  13. 18 November 1993

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 103-379, Part I.

    Source: Committee

  14. 18 November 1993

    Reported

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 103-379, Part I.

    Source: Committee

  15. 21 November 1993

    Passed

    Motion to reconsider laid on the table Agreed to without objection.

    Source: Floor

  16. 21 November 1993

    Passed

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    Source: Floor

  17. 21 November 1993

    Passed

    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    Source: Floor

  18. 21 November 1993

    Floor

    DEBATE - The House proceeded with forty minutes of debate.

    Source: Floor

  19. 21 November 1993

    Floor

    Mr. Waxman moved to suspend the rules and pass the bill, as amended.

    Source: Floor

  20. 21 November 1993

    Floor

    Considered under suspension of the rules. (consideration: CR H10541-10545)

    Source: Floor

  21. 22 November 1993

    Introduced

    Received in the Senate, read twice.

    Source: IntroReferral

  22. 24 November 1993

    Passed

    Passed Senate without amendment by Voice Vote. (consideration: CR S17225)

    Source: Floor

  23. 24 November 1993

    Passed

    Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S17225)

    Source: Floor

  24. 26 November 1993

    Floor

    Message on Senate action sent to the House.

    Source: Floor

  25. 8 December 1993

    Floor

    Presented to President.

    Source: Floor

  26. 8 December 1993

    President

    Presented to President.

    Source: President

  27. 17 December 1993

    Became law

    Became Public Law No: 103-200.

    Source: President

  28. 17 December 1993

    Became law

    Signed by President.

    Source: BecameLaw

  29. 17 December 1993

    President

    Signed by President.

    Source: President

Votes

No vote records are attached yet.

Versions

Documents

11 official files

Public Law (PDF)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.